James R. Meyers - 25 Nov 2025 Form 4 Insider Report for Vera Therapeutics, Inc. (VERA)

Role
Director
Signature
/s/ Joseph Young, attorney-in-fact
Issuer symbol
VERA
Transactions as of
25 Nov 2025
Net transactions value
$0
Form type
4
Filing time
26 Nov 2025, 16:37:03 UTC
Previous filing
16 Jun 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Meyers James R Director C/O VERA THERAPEUTICS, INC. 2000 SIERRA, POINT PARKWAY, SUITE 1200, BRISBANE /s/ Joseph Young, attorney-in-fact 26 Nov 2025 0001387521

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction VERA Stock Option (right to buy) Award $0 +25,000 $0.000000 25,000 25 Nov 2025 Class A Common Stock 25,000 $29.43 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares subject to the stock option will vest monthly over a three-year period subject to the Reporting Person's continuous service on each vesting date. Notwithstanding the foregoing, the shares will vest in full upon a change in control, subject to the Reporting Person's continuous service through the date of such change in control.